CARDIOVASCULAR DRUGS AND THERAPY（心血管药物和治疗杂志）影响因子_期刊投稿发表

期刊简介

Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field.Homing in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focusses on developments in atherosclerosis, hyperlipidemia, diabetes, ischemic syndromes and arrhythmias. The Journal is an authoritative source of current and relevant information that is indispensable for basic and clinical investigators aiming for novel, breakthrough research as well as for cardiologists seeking to best serve their patients.Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Web of Science and PubMed/Medline among other abstracting and indexing services. The regular articles and frequent special topical issues equip you with an up-to-date source defined by the need for accurate information on an ever-evolving field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of new products and therapies which furnishes you with the details on cardiovascular pharmacology that you will refer to time and time again.

《心血管药物与治疗》旨在客观地涵盖心血管药物、设备和细胞治疗从实验室到临床的发展过程，并以及时和有用的形式为您提供您最需要的信息，以新鲜和充满活力的眼光看待这一动态领域的进展。高脂血症、糖尿病、局部缺血综合征和心律失常。期刊是当前和相关信息的权威来源，对于致力于创新、突破性研究的基础和临床研究者以及寻求最佳患者服务的心脏病专家来说，是不可或缺的。为您提供公认为世界上最好的单一、简洁的参考工具。心血管药物和治疗在Web of Science和PubMed/Medline以及其他摘要和索引服务中列出。定期的文章和经常性的专题问题为您提供了一个最新的来源，定义为对一个不断发展的领域的准确信息的需要。心血管药物和治疗是一个仔细和准确的指南，通过迷宫的新产品和治疗，为您提供了详细的心血管药理学，您将参考一次又一次。

《CARDIOVASCULAR DRUGS AND THERAPY》期刊已被查看：次

分区信息